Author:
Langford H. Marie,Williams Peter D.,Homnick Carl F.,Vacca Joseph P.,Felock Peter J.,Stillmock Kara A.,Witmer Marc V.,Hazuda Daria J.,Gabryelski Lori J.,Schleif William A.
Subject
Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry
Reference18 articles.
1. HIV-1 Integrase: A Target for New AIDS Chemotherapeutics
2. Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial
3. Raltegravir: a new antiretroviral class for salvage therapy
4. Miller, M.; Witmer, M.; Stillmock, K.; Felock, P.; Ecto, L.; Flynn, J.; Schleif, W.; Donradula, G.; Danovich, R.; Hazuda, D. International AIDS Conference, 2006, Toronto, Canada, Abstract No. ThAa0302.
5. 8-Hydroxy-3,4-dihydropyrrolo[1,2-a]pyrazine-1(2H)-one HIV-1 integrase inhibitors
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献